SCHEMBL356542

SCHEMBL356542

CNCC=O.COC(C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6993079 0.79 ADH1B (0.41)
SCHEMBL762036 0.79
SCHEMBL9839894 0.76
Hydrochloric Acid SCHEMBL22322226 0.76
Propionaldehyde SCHEMBL1412137 0.74 ALDH1A1 (0.53)
Malonaldehyde SCHEMBL8113991 0.74 ALDH1A1 (0.30)
SCHEMBL8808939 0.74 ADH1B (0.36)
Isobutyraldehyde SCHEMBL9790327 0.73
SCHEMBL483681 0.72
SCHEMBL2075451 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021052269-A1 WATER-SOLUBLE COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF 广东省禾基生物科技有限公司 2021-03-25 WO claimed
WO-2021052270-A1 HONOKIOL DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 广东省禾基生物科技有限公司 2021-03-25 WO claimed
WO-2021052271-A1 MAGNOLOL DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 广东省禾基生物科技有限公司 2021-03-25 WO claimed
US-20210053983-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2021-02-25 US claimed
EP-3752508-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF Sunovion Pharmaceuticals Inc. (US) 2020-12-23 EP claimed
US-20190256525-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF SUNOVION PHARMACEUTICALS INC. 2019-08-22 US claimed
WO-2019161238-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2019-08-22 WO claimed
EP-2245132-B1 ENCAPSULATED BENEFIT AGENT UNILEVER PLC NO 41424 (GB) 2017-10-18 EP claimed
JP-63290851-A None JP disclosed
US-20260125393-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2026-05-07 US disclosed
US-20250136550-A1 PROCESSES FOR PREPARING REVEFENACIN AND COMPOSITIONS COMPRISING THE SAME THERAVANCE BIOPHARMA R&D IP, LLC 2025-05-01 US disclosed
US-20240425516-A1 SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2024-12-26 US disclosed
US-20240417382-A1 SALTS OF A HETEROCYCLIC COMPOUND AND CRYSTALLINE FORMS, PROCESSES FOR PREPARING, THERAPEUTIC USES, AND PHARMACEUTICAL COMPOSITIONS THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2024-12-19 US disclosed
CN-118406063-A Salt, crystal forms and preparation method thereof 赛诺维信制药公司 2024-07-30 CN disclosed
US-4252960-A PREEMERGENCE HERBICIDES PPG INDUSTRIES, INC. (US) 1981-02-24 US disclosed
US-4252961-A Intermediates of and process for making 3-[5-[1-(2-, 3-, or 4-methyl, or ethyl or isopropylphenoxy)alkyl, alkynyl, alkenyl, or haloalkyl]-1,3,4-thiadiazol-2-yl]-4-hydroxy-1-methyl-2-imidazolidinones PPG INDUSTRIES, INC. (US) 1981-02-24 US disclosed
US-4230480-A 3-[5-(1-(Nitrophenoxy)alkyl, alkynyl, alkenyl, or haloalkyl)-1,3,4-thiadiazol-2-yl]-4-hydroxy-1-methyl-2-imidazolidinones PPG INDUSTRIES, INC. (US) 1980-10-28 US disclosed
US-4218236-A PREEMERGENCE AND POSTEMERGENCE HERBICIDES PPG INDUSTRIES, INC. (US) 1980-08-19 US disclosed
US-4165229-A SUBSTITUTED THIADIAZOL-2-YLUREA ELI LILLY AND COMPANY (US) 1979-08-21 US disclosed
US-3998827-A HYPOTENSIVE AGENTS THE UPJOHN COMPANY (US) 1976-12-21 US disclosed